Category: DAIC Articles

Resolute Integrity Now Indicated for CTOs

April 03, 2019

Medtronic’s Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions.

Visit Website
Page 5 of 50«...34567...101520253035404550...»